UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-08 | -0.44 | -0.44 |
| Q1 2022 | 2022-05-05 | -0.55 | -0.55 |
| Q4 2021 | 2022-03-01 | -0.58 | -0.58 |
| Q3 2021 | 2021-11-09 | -0.32 | -0.32 |
| Q2 2021 | 2021-08-09 | -0.56 | -0.56 |
| Q1 2021 | 2021-04-29 | -0.43 | -0.43 |
| Q4 2020 | 2021-03-01 | -0.43 | -0.43 |
| Q3 2020 | 2020-11-02 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-10 | 0.29 | 0.29 |
| 2016-05-19 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-01-07 | Reiterated Rating | Cowen and Company | Market Perform | |
| 2015-09-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $7.00 to $14.00 |
| 2014-11-06 | Downgrade | Cowen and Company | Outperform to Market Perform | |
| 2014-01-13 | Initiated Coverage | Goldman Sachs | Neutral | $7.00 |
| 2013-12-04 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2012-11-14 | Initiated | Stifel Nicolaus | Buy | $16 |
| 2016-05-19 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-03-14 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-01-07 | Reiterated Rating | Cowen and Company | Market Perform | |
| 2015-09-24 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $7.00 to $14.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CCXI 163 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 6.02M |
| BlackRock Inc. | 4.84M |
| STATE STREET CORP | 2.72M |
| Pentwater Capital Management LP | 1.80M |
| BAKER BROS. ADVISORS LP | 1.79M |
| SOROS FUND MANAGEMENT LLC | 1.58M |
| BlackRock Fund Advisors | 1.41M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.15M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 0.85M |
| Nuveen Asset Management, LLC | 0.85M |
| Invesco Ltd. | 0.83M |
| FARALLON CAPITAL MANAGEMENT LLC | 0.80M |
| GLAZER CAPITAL, LLC | 0.79M |
| CARLSON CAPITAL L P | 0.75M |
| WATER ISLAND CAPITAL LLC | 0.74M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Schall Thomas J. President and CEO | 5.04% (2184994) | CCXI / |
| Edwards Thomas A. | 0.32% (138785) | CCXI / |
| LUCAS ROGER C | 0.22% (93846) | CCXI / TECH / |
| FECZKO JOSEPH M | 0.19% (82096) | CCXI / KERX / |
| Bekker Petrus SVP of Medical & Clinical | 0.14% (59839) | CCXI / |
| Tyree James L | 0.12% (53849) | CCXI / DEPO / THRX / |
| Parker Geoffrey M. | 0.11% (45671) | ANAC / CCXI / GHDX / PRGO / SNSS / |
| MCKINNELL HENRY A | 0.10% (44218) | CCXI / MCO / |
| KANAYA SUSAN M SVP, Finance, CFO and Sec. | 0.09% (38135) | CCXI / |
| Jaen Juan C. SVP, Drug Discovery & CSO | 0.07% (30000) | CCXI / |
| Cappel Markus J. Chief Bus. Officer & Treasurer | 0.05% (23826) | CCXI / |
| KLEIN IRA | 0.04% (16216) | CCXI / |
| SINGH RAJINDER SVP, Research | 0.02% (10000) | CCXI / |
UM